Skip to main content

Table 4 Subgroup analyses for IL-10 −592C>A polymorphism and urologic cancer risk

From: Associations of IL-10 genetic polymorphisms with the risk of urologic cancer: a meta-analysis based on 18,415 subjects

Variables

P value

OR (95% Cl)

I-square (%)

P for the heterogeneity

Cancer type

Prostate cancer (No.a: 10)

 CC versus CA

0.99

1.00 (0.87–1.15)

49

0.05

 CC versus AA

0.51

0.94 (0.80–1.12)

22

0.25

 CA versus AA

0.37

0.93 (0.79–1.09)

0

0.85

 CC versus CA+AA

0.85

0.99 (0.85–1.14)

56

0.02

 CA versus CC+AA

0.97

1.00 (0.91–1.09)

36

0.13

 AA versus CC+CA

0.47

1.06 (0.91–1.23)

0

0.54

 C versus A

0.55

0.97 (0.89–1.07)

49

0.04

Renal cancer (No.a: 3)

 CC versus CA

0.35

1.21 (0.80–1.83)

0

0.50

 CC versus AA

0.47

1.26 (0.67–2.36)

0

0.83

 CA versus AA

0.94

0.99 (0.65–1.49)

0

0.50

 CC versus CA+AA

0.30

1.23 (0.83–1.82)

0

0.66

 CA versus CC+AA

0.40

0.87 (0.63–1.20)

0

0.39

 AA versus CC+CA

0.98

1.00 (0.67–1.47)

0

0.56

 C versus A

0.48

1.10 (0.85–1.41)

0

0.55

Bladder cancer (No.a: 1)

 CC versus CA

0.30

0.79 (0.50–1.23)

NA

NA

 CC versus AA

0.002

0.51 (0.33–0.78)

NA

NA

 CA versus AA

0.004

0.64 (0.48–0.87)

NA

NA

 CC versus CA+AA

0.02

0.62 (0.41–0.93)

NA

NA

 CA versus CC+AA

0.04

0.74 (0.56–0.99)

NA

NA

 AA versus CC+CA

0.0004

1.65 (1.25–2.19)

NA

NA

 C versus A

0.00001

0.66 (0.54–0.82)

NA

NA

Ethnicity

Asian (No.a: 4)

 CC versus CA

0.57

1.07 (0.84–1.37)

0

0.44

 CC versus AA

0.70

0.91 (0.55–1.50)

68

0.03

 CA versus AA

0.05

0.82 (0.68–1.00)

40

0.17

 CC versus CA+AA

0.93

0.98 (0.66–1.46)

58

0.07

 CA versus CC+AA

0.06

0.85 (0.71–1.01)

0

0.58

 AA versus CC+CA

0.38

1.15 (0.84–1.58)

66

0.03

 C versus A

0.61

0.93 (0.70–1.23)

78

0.003

Caucasian (No.a: 7)

 CC versus CA

0.89

0.99 (0.86–1.13)

52

0.06

 CC versus AA

0.31

0.87 (0.66–1.14)

0

0.58

 CA versus AA

0.37

0.88 (0.66–1.16)

0

0.75

 CC versus CA+AA

0.84

0.98 (0.80–1.20)

53

0.06

 CA versus CC+AA

1.00

1.00 (0.82–1.22)

49

0.08

 AA versus CC+CA

0.30

1.15 (0.88–1.51)

0

0.70

 C versus A

0.31

0.96 (0.88–1.04)

35

0.16

  1. The difference in cases and controls regarding the distributions of investigated genetic polymorphisms in certain genetic model reached the statistically significant level, which is also less than 0.05 are indicated in italics
  2. OR odds ratio, CI confidence interval, NA not applicable
  3. aThe number of articles